Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes

Optometry and Vision Science

Volumn 95, Issue 12, 2018, Pages 1149-1154

  Ozkaya, Abdullah ^a   Tarakcioglu, Hatice Nur ^a   Tanir, Ipek ^a  

^a Beyoglu Eye Training and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

OPHTHALMOLOGY; PATIENT TREATMENT; VISION;

DEXAMETHASONES; INTRA OCULAR PRESSURE; LENS OPACITY; MACULAR EDEMA; OUTCOME MEASURES; REAL-WORLD; VISUAL ACUITY;

ALDEHYDES;

ANGIOGENESIS INHIBITOR; DEXAMETHASONE; GLUCOCORTICOID; RANIBIZUMAB; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; COMPARATIVE STUDY; COMPLICATION; DRUG IMPLANT; FEMALE; HUMAN; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MALE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RANIBIZUMAB; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 85057764827     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0000000000001306     Document Type: Article

References (31)

1. The Branch Vein Study Group. Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion. Am J Ophthalmol 1984;98:271-82.
2. Jonas J, PaquesM, Mones J, et al. Retinal Vein Occlusions. Dev Ophthalmol 2010;47:111-35.
3. Karacorlu M, Ozdemir H, Karacorlu SA. Resolution of Serous Macular Detachment After Intravitreal Triamcinolone Acetonide Treatment of Patients with Branch Retinal Vein Occlusion. Retina 2005;25:856-60.
4. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal Bevacizumab (Avastin) Treatment of Macular Edema in Central Retinal Vein Occlusion: A Short-term Study. Retina 2006;26:279-84.
5. Ozkaya A, Celik U, Alkin Z, et al. Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion. ISRN Ophthalmol 2013;2013:141279.
6. Chang LK, Spaide RF, Klancnik JM, et al. Longerterm Outcomes of a Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion. Retina 2011;31:821-8.
7. Clark WL, Boyer DS, Heier JS, et al. Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-week Results of the VIBRANT Study. Ophthalmology 2016;123:330-6.
8. Funk M, Kriechbaum K, Prager F, et al. Intraocular Concentrations of Growth Factors and Cytokines in Retinal Vein Occlusion and the Effect of Therapy with Bevacizumab. Invest Ophthalmol Vis Sci 2009;50: 1025-32.
9. Brown DM, Campochiaro PA, Bhisitkul RB, et al. Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-month Outcomes of a Phase III Study. Ophthalmology 2011;118:1594-602.
10. Miwa Y, Muraoka Y, Osaka R, et al. Ranibizumab for Macular Edema After Branch Retinal Vein Occlusion: One Initial Injection versus Three Monthly Injections. Retina 2017;37:702-9.
11. Ozkaya A, Alkin Z, Yesilkaya C, et al. Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion in a Real Life Practice: A Retrospective Case Series. Beyoglu Eye J 2016;1:5-9.
12. Haller JA, Bandello F, Belfort R, Jr., et al. Ozurdex GENEVA Study Group. Dexamethasone Intravitreal Implant in Patients withMacular Edema Related to Branch or Central Retinal Vein Occlusion Twelve-month Study Results. Ophthalmology 2011;118:2453-60.
13. Korobelnik JF, Kodjikian L, Delcourt C, et al. Twoyear, Prospective, Multicenter Study of the Use of Dexamethasone Intravitreal Implant for Treatment of Macular Edema Secondary to Retinal Vein Occlusion in the Clinical Setting in France. Graefes Arch Clin Exp Ophthalmol 2016;254:2307-18.
14. Dugel PU, Capone A, Jr., Singer MA, et al. Two or More Dexamethasone Intravitreal Implants in Treatmentnaive Patients with Macular Edema Due to Retinal Vein Occlusion: Subgroup Analysis of a Retrospective Chart Review Study. BMC Ophthalmol 2015;15:118.
15. Joshi L, Yaganti S, Gemenetzi M, et al. Dexamethasone Implants in Retinal Vein Occlusion: 12-month Clinical Effectiveness Using Repeat Injections Asneeded. Br J Ophthalmol 2013;97:1040-4.
16. Eter N, Mohr A, Wachtlin J, et al. Dexamethasone Intravitreal Implant in Retinal Vein Occlusion: Real-life Data from a Prospective, Multicenter Clinical Trial. Graefes Arch Clin Exp Ophthalmol 2017;255:77-87.
17. Chiquet C, Dupuy C, Bron AM, et al. Intravitreal Dexamethasone Implant versus Anti-VEGF Injection for Treatment-naïve Patients with Retinal Vein Occlusion and Macular Edema: A 12-month Follow-up Study. Graefes Arch Clin Exp Ophthalmol 2015;253:2095-102.
18. Hattenbach LO, Feltgen N, Bertelmann T, et al. Head-to-head Comparison of Ranibizumab PRN versus Single-dose Dexamethasone for Branch Retinal Vein Occlusion (COMRADE-B). Acta Ophthalmol 2018;96: e10-8.
19. Gu X, Yu X, Song S, et al. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population. Ophthalmic Res 2017;58:8-14.
20. Yuksel B, Karti O, Celik O, et al. Low Frequency Ranibizumab versus Dexamethasone Implant for Macular Oedema Secondary to Branch Retinal Vein Occlusion. Clin Exp Optom 2018;101:116-22.
21. Nghiem-Buffet S, Fajnkuchen F, BuffetM, et al. Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion. Ophthalmologica 2014;232:216-22.
22. Chylack LT, Jr., Wolfe JK, SingerDM, et al. The Lens Opacities Classification System I?I?I. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993; 111:831-6.
23. Ozkaya A, OzverenM, Alkin Z. Intravitreal Ranibizumab for Diabetic Macular Edema Patients with Good Baseline Visual Acuity: A Real-life Study. Beyoglu Eye J 2017;2:53-7.
24. Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: Six-month Primary End Point Results of a Phase I?I?I Study. Ophthalmology 2010; 117:1102-12. e1.
25. Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab forMacular Edema Due to Retinal Vein Occlusions: Longterm Follow-up in the HORIZON Trial. Ophthalmology 2012;119:802-9.
26. Chatziralli I, Theodossiadis G, Chatzirallis A, et al. Ranibizumab for Retinal Vein Occlusion: Predictive Factors and Long-term Outcomes in Real-life Data. Retina 2018;38:559-68.
27. Lip PL, Cikatricis P, Sarmad A, et al. Efficacy and Timing of Adjunctive Therapy in the Anti-VEGF Treatment Regimen for Macular Oedema in Retinal Vein Occlusion: 12-month Real-world Result. Eye (Lond) 2018;32:537-45.
28. Querques L, Querques G, Lattanzio R, et al. Repeated Intravitreal Dexamethasone Implant (Ozurdex®) for Retinal Vein Occlusion. Ophthalmologica 2013; 229:21-5.
29. Bandello F, ParravanoM, Cavallero E, et al. Prospective Evaluation of Morphological and Functional Changes After Repeated Intravitreal Dexamethasone Implant (Ozurdex®) for Retinal Vein Occlusion. Ophthalmic Res 2015;53: 207-16.
30. Querques G, Cascavilla ML, Cavallero E, et al. Changes in Macular Function After Ozurdex for Retinal Vein Occlusion. Optom Vis Sci 2014;91:760-8.
31. Cai S, Bressler NM. Aflibercept, Bevacizumab or Ranibizumab for Diabetic Macular Oedema: Recent Clinically Relevant Findings from Drcr. Net Protocol T Curr Opin Ophthalmol 2017;28:636-43.